发现ATX968:一种口服可用的DHX9的菌抑制剂
Matthew H Daniels1, Jennifer Castro1, Young-Tae Lee1
1Accent Therapeutics, Inc., 1050 Waltham Street, Lexington, Massachusetts 02421, United States.
Journal of medicinal chemistry
|April 29, 2025
概括
研究人员发现了用于癌症治疗的新型DHX9抑制剂. ATX968是一种强大的DHX9抑制剂,在微卫星不稳定性高的结直肠癌模型中显示出有效性,突出显示了药物效力的停留时间的重要性.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- DHX9 (DEAH-box酶9) 对于保持基因组稳定性至关重要.
- DHX9是癌症药物发现的有希望的治疗标.
研究的目的:
- 为了发现和优化新的DHX9抑制剂.
- 为了研究结合动力学和细胞活性之间的关系.
主要方法:
- 基于结构的药物设计利用X射线晶体学.
- 生物化学测定测量ATPase和解活动.
- 在瘤异种移植模型中的体内疗效研究.
主要成果:
- 化合物1表明选择性抑制DHX9解活动.
- 一个硫-素键增强了在目标上的停留时间.
- 细胞强度与停留时间的相关性比平衡结合亲和力更好.
- ATX968是一种强大的DHX9抑制剂,在MSI-H结直肠癌模型中显示出有效性.
结论:
- DHX9抑制剂代表了瘤学的可行的治疗策略.
- 优化停留时间对于开发强大的DHX9抑制剂至关重要.
- ATX968是治疗MSI-H结肠直肠癌的一个有希望的候选人.
更多相关视频
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
13.6K
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
6.6K
相关概念视频
Allosteric Regulation
53.3K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
53.3K
Inheritance of Chromatin Structures
6.0K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.0K
Exon Recombination
3.1K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.1K
Allosteric Proteins-ATCase
4.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
